Literature DB >> 18615230

Ace inhibitors as a therapy for sarcopenia - evidence and possible mechanisms.

D Sumukadas1, M D Witham, A D Struthers, M E T McMurdo.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18615230     DOI： 10.1007/BF02982709

Source DB:  PubMed          Journal:  J Nutr Health Aging        ISSN： 1279-7707            Impact factor:   4.075


× No keyword cloud information.
  69 in total

1.  Asymptomatic peripheral arterial disease is independently associated with impaired lower extremity functioning: the women's health and aging study.

Authors:  M M McDermott; L Fried; E Simonsick; S Ling; J M Guralnik
Journal:  Circulation       Date:  2000-03-07       Impact factor: 29.690

2.  Effect of angiotensin-converting enzyme inhibition on skeletal muscle oxidative function and exercise capacity in streptozotocin-induced diabetic rats.

Authors:  Olivier Rouyer; Joffrey Zoll; Frederic Daussin; Christiane Damgé; Pauline Helms; Sami Talha; Laurence Rasseneur; Francois Piquard; Bernard Geny
Journal:  Exp Physiol       Date:  2007-08-03       Impact factor: 2.969

3.  Respiratory muscle work compromises leg blood flow during maximal exercise.

Authors:  C A Harms; M A Babcock; S R McClaran; D F Pegelow; G A Nickele; W B Nelson; J A Dempsey
Journal:  J Appl Physiol (1985)       Date:  1997-05

4.  Peripheral arterial disease in the elderly: The Rotterdam Study.

Authors:  W T Meijer; A W Hoes; D Rutgers; M L Bots; A Hofman; D E Grobbee
Journal:  Arterioscler Thromb Vasc Biol       Date:  1998-02       Impact factor: 8.311

5.  Low relative skeletal muscle mass (sarcopenia) in older persons is associated with functional impairment and physical disability.

Authors:  Ian Janssen; Steven B Heymsfield; Robert Ross
Journal:  J Am Geriatr Soc       Date:  2002-05       Impact factor: 5.562

6.  Improved exercise tolerance after losartan and enalapril in heart failure: correlation with changes in skeletal muscle myosin heavy chain composition.

Authors:  G Vescovo; L Dalla Libera; F Serafini; C Leprotti; L Facchin; M Volterrani; C Ceconi; G B Ambrosio
Journal:  Circulation       Date:  1998-10-27       Impact factor: 29.690

7.  Left ventricular diastolic dysfunction in elderly hypertensives: results of the APROS-diadys study.

Authors:  Alberto Zanchetti; Cesare Cuspidi; Lisa Comarella; Enrico Agabiti Rosei; Ettore Ambrosioni; Massimo Chiariello; Gastone Leonetti; Giuseppe Mancia; Achille C Pessina; Antonio Salvetti; Bruno Trimarco; Massimo Volpe; Nicoletta Grassivaro; Giuseppe Vargiu
Journal:  J Hypertens       Date:  2007-10       Impact factor: 4.844

8.  Satellite cells and myonuclei in young and elderly women and men.

Authors:  Fawzi Kadi; Nadia Charifi; Christian Denis; Jan Lexell
Journal:  Muscle Nerve       Date:  2004-01       Impact factor: 3.217

9.  Tissue availability of insulin-like growth factor I is inversely related to insulin resistance in essential hypertension: effects of angiotensin converting enzyme inhibition.

Authors:  C Laviades; M J Gil; I Monreal; A González; J Díez
Journal:  J Hypertens       Date:  1998-06       Impact factor: 4.844

10.  Effect of angiotensin-converting enzyme inhibition on endothelial function and insulin sensitivity in hypertensive patients.

Authors:  Hakan Tezcan; Dilek Yavuz; Ahmet Toprak; Ihsan Akpinar; Mehmet Koç; Oguzhan Deyneli; Sema Akalin
Journal:  J Renin Angiotensin Aldosterone Syst       Date:  2003-06       Impact factor: 1.636
View more
  9 in total

1.  Effect of Antihypertensive and Statin Medication Use on Muscle Performance in Community-Dwelling Older Adults Performing Strength Training.

Authors:  Mohammad Alturki; Keliane Liberman; Andreas Delaere; Liza De Dobbeleer; Veerle Knoop; Tony Mets; Siddhartha Lieten; Bert Bravenboer; Ingo Beyer; Ivan Bautmans
Journal:  Drugs Aging       Date:  2021-02-05       Impact factor: 3.923

Review 2.  Functional consequences of sarcopenia and dynapenia in the elderly.

Authors:  Brian C Clark; Todd M Manini
Journal:  Curr Opin Clin Nutr Metab Care       Date:  2010-05       Impact factor: 4.294

3.  Angiotensin-Converting Enzyme Inhibitors and Parameters of Sarcopenia: Relation to Muscle Mass, Strength and Function: Data from the Berlin Aging Study-II (BASE-II).

Authors:  Dominik Spira; Jeremy Walston; Nikolaus Buchmann; Jivko Nikolov; Ilja Demuth; Elisabeth Steinhagen-Thiessen; Rahel Eckardt; Kristina Norman
Journal:  Drugs Aging       Date:  2016-11       Impact factor: 3.923

Review 4.  Impact of nutrition on muscle mass, strength, and performance in older adults.

Authors:  A Mithal; J-P Bonjour; S Boonen; P Burckhardt; H Degens; G El Hajj Fuleihan; R Josse; P Lips; J Morales Torres; R Rizzoli; N Yoshimura; D A Wahl; C Cooper; B Dawson-Hughes
Journal:  Osteoporos Int       Date:  2012-12-18       Impact factor: 4.507

Review 5.  Advantages of dietary, exercise-related, and therapeutic interventions to prevent and treat sarcopenia in adult patients: an update.

Authors:  D L Waters; R N Baumgartner; P J Garry; B Vellas
Journal:  Clin Interv Aging       Date:  2010-09-07       Impact factor: 4.458

6.  Leucine and ACE inhibitors as therapies for sarcopenia (LACE trial): study protocol for a randomised controlled trial.

Authors:  Margaret M Band; Deepa Sumukadas; Allan D Struthers; Alison Avenell; Peter T Donnan; Paul R Kemp; Karen T Smith; Cheryl L Hume; Adrian Hapca; Miles D Witham
Journal:  Trials       Date:  2018-01-04       Impact factor: 2.279

7.  Pre-sarcopenia is associated with renal hyperfiltration independent of obesity or insulin resistance: Nationwide Surveys (KNHANES 2008-2011).

Authors:  Eugene Han; Yong-Ho Lee; Byung-Wan Lee; Eun Seok Kang; Bong-Soo Cha
Journal:  Medicine (Baltimore)       Date:  2017-06       Impact factor: 1.889

Review 8.  Milk for Skeletal Muscle Health and Sarcopenia in Older Adults: A Narrative Review.

Authors:  Christopher Hurst; Lorelle Dismore; Antoneta Granic; Terry Aspray; Emma Stevenson; Miles D Witham; Avan A Sayer; Sian Robinson
Journal:  Clin Interv Aging       Date:  2020-05-20       Impact factor: 4.458

Review 9.  Muscle Wasting and Sarcopenia in Heart Failure-The Current State of Science.

Authors:  Alessia Lena; Markus S Anker; Jochen Springer
Journal:  Int J Mol Sci       Date:  2020-09-08       Impact factor: 5.923
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.